Data / Form D filings / RYNE Biotechnology Inc.
RYNE Biotechnology Inc.: Form D filings
RYNE Biotechnology Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on March 1, 2024, reports $30 million sold of a $81.8 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BROADWAY, 14TH FLOOR KENDALL SQUARE, Cambridge, MA, 02142
- Phone
- (815) 505-6466
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1938657
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | New notice | $81,832,753 | $30,000,000 | $51,832,753 | 9 | Feb 26, 2024 | sec.gov |
| Jul 20, 2022 | New notice | $5,000,000 | $3,000,000 | $2,000,000 | 1 | Jun 13, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeff Goater | Director | |
| Peter Fuhrken | Director | |
| Howard Federoff | Executive Officer, Director | |
| Nick Manusos | Executive Officer, Director | |
| David Fallace | Director | |
| Jeff Jonas | Director | |
| Martin Ostrowski | Executive Officer | |
| Jonathan Yeh | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 26, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RYNE Biotechnology Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.